Product Description
Point-of-Care Glucose Analyzer
CLIA Waived
Hemocue 120706″ title=”HemoCueGlucose 201
Point-of-Care Glucose Analyzer
CLIA Waived
Hemocue 120706″ />HemoCueGlucose 201
Point-of-Care Glucose Analyzer
CLIA Waived
Hemocue 120706
Manufacturer 120706Brand HemoCue® Glucose 201Manufacturer HemocueApplication Point-of-Care Glucose AnalyzerCLIA Classification CLIA WaivedDimensions 3.35 X 6.30 X 1.69 InchFor Use With HemoCue® Glucose 201 MicrocuvetteNumber of Tests 1 TestReadout Type Digital DisplaySample Type Capillary / Venous / Aterial Whole Blood SampleTest Name Blood Glucose LevelTest Time 4 Minute ResultsUNSPSC Code 41116201Weight 0.77 lbs.Features
Hemocue glucose testing systems are based on a glucose dehydrogenase method and consist of a small dedicated analyzer and a unique disposable microcuvette No calibration or microcuvette batch-to-batch variations Glucose 201 analyzer: 0-444 mg/dl (0-24.6 mmol/l) Lab-accurate results Only 5 µL of capillary, venous, or arterial blood is needed Following the three simple steps, the hemocue glucose systems will produce lab-accurate results for diagnosing or monitoring diabetes, as well as monitoring neonatal blood glucose levels
